Unlicensed and off-label drug use in a neonatal unit in France

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 4, 2011, Pages 615-617

  Nguyen, Kim An ^a,b   Claris, Olivier ^a   Kassai, Behrouz ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMIKACIN; ASCORBIC ACID; CAFFEINE CITRATE; DOMPERIDONE; ERGOCALCIFEROL; FOLINATE CALCIUM; GAVISCON; PENICILLIN G; PHYTOMENADIONE; RECOMBINANT ERYTHROPOIETIN; RETINOL; SODIUM CHLORIDE; VITAMIN D;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG INDICATION; FRANCE; GESTATIONAL AGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEWBORN; OFF LABEL DRUG USE; PHYSICIAN ATTITUDE; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

CROSS-SECTIONAL STUDIES; DRUG APPROVAL; FRANCE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES;

EID: 79952748659     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.02103.x     Document Type: Article

References (14)

1. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005; 164: 552-8. (Pubitemid 41225059)
2. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006; 5: 703-18. (Pubitemid 44322888)
3. Conroy S, McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med 2005; 10: 115-22. (Pubitemid 40215539)
4. Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C. [The incidence of prescriptions without marketing product license in a neonatal intensive care unit]. Arch Pediatr 2000; 7: 143-7.
5. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80: F142-4. discussion F4-5.
6. Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007; 29: 361-7. (Pubitemid 47196657)
7. O'Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110: e52.
8. Prandstetter C, Tamesberger M, Wagner O, Weissensteiner M, Wiesinger-Eidenberger G, Weidinger I, et al. [Medical prescriptions to premature and newborn infants in an Austrian neonatal intensive care unit]. Klin Padiatr 2009; 221: 312-7.
9. Franz AR, Mihatsch WA, Sander S, Kron M, Pohlandt F. Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams. Pediatrics 2000; 106: 700-6.
10. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, et al. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics 2006; 118: 180-8. (Pubitemid 46071161)
11. Muller AE, DeJongh J, Bult Y, Goessens WH, Mouton JW, Danhof M, et al. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks. Antimicrob Agents Chemother 2007; 51: 3720-5.
12. Padovani EM, Pistolesi C, Fanos V, Messori A, Martini N. Pharmacokinetics of amikacin in neonates. Dev Pharmacol Ther 1993; 20: 167-73.
13. Siddiqi A, Khan DA, Khan FA, Razzaq A. Therapeutic drug monitoring of amikacin in preterm and term infants. Singapore Med J 2009; 50: 486-9.
14. Mehta DK. BNF for children: listening and learning. Arch Dis Child Educ Pract Ed 2007; 92: ep144-8.